ES8600218A1 - Procedimiento para preparar un derivado de insulina - Google Patents
Procedimiento para preparar un derivado de insulinaInfo
- Publication number
- ES8600218A1 ES8600218A1 ES535916A ES535916A ES8600218A1 ES 8600218 A1 ES8600218 A1 ES 8600218A1 ES 535916 A ES535916 A ES 535916A ES 535916 A ES535916 A ES 535916A ES 8600218 A1 ES8600218 A1 ES 8600218A1
- Authority
- ES
- Spain
- Prior art keywords
- aminoacid
- radical
- insulin derivatives
- aminoacids
- neutral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
- 150000001371 alpha-amino acids Chemical class 0.000 abstract 4
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 4
- 230000007935 neutral effect Effects 0.000 abstract 4
- 125000000962 organic group Chemical group 0.000 abstract 4
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 102000005593 Endopeptidases Human genes 0.000 abstract 1
- 108010059378 Endopeptidases Proteins 0.000 abstract 1
- 239000004026 insulin derivative Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001810 trypsinlike Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Abstract
METODO DE PREPARACION DE DERIVADOS DE INSULINA, DE FORMULA (I), EN LA QUE R1 ES HIDROGENO O H-PHE; R30 ES EL RADICAL DE UN L-AMINOACIDO NEUTRO PRESENTE EN LA NATURALEZA; Y R31 ES UN GRUPO ORGANICO INOCUO FISIOLOGICAMENTE, DE CARACTER NEUTRO O BASICO Y QUE TIENE UN PUNTO ISOELECTRICO SUPERIOR A 5,8.COMPRENDE LA REACCION DE UNA INSULINA, DE FORMULA (I), EN LA QUE R1 ES H O H-PHE; R30 ES EL RADICAL DE UN L-AMINOACIDO CODIFICABLE GENETICAMENTE Y R31 ES OH O UN GRUPO PROTECTOR DE LA FUNCION CARBOXI, O DE UNA PROINSULINA, O COMPUESTO ANALOGO, UNA PREPROINSULINA O COMPUESTO ANALOGO, CON UN PEPTIDO O DERIVADO DE AMINOACIDO, DE FORMULA H-R30-R31, EN PRESENCIA DE TRIPSINA O DE UNA ENDOPEPTIDASA SIMILAR, A UN PH INFERIOR AL PUNTO ISOELECTRICO DE LAS INSULINAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833333640 DE3333640A1 (de) | 1983-09-17 | 1983-09-17 | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8600218A1 true ES8600218A1 (es) | 1985-10-01 |
| ES535916A0 ES535916A0 (es) | 1985-10-01 |
Family
ID=6209365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES535916A Granted ES535916A0 (es) | 1983-09-17 | 1984-09-14 | Procedimiento para preparar un derivado de insulina |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5015728A (es) |
| EP (1) | EP0140084B1 (es) |
| JP (1) | JPH0691834B2 (es) |
| KR (1) | KR850002282A (es) |
| AT (1) | ATE53590T1 (es) |
| AU (1) | AU577801B2 (es) |
| CA (1) | CA1246478A (es) |
| DE (2) | DE3333640A1 (es) |
| DK (1) | DK172462B1 (es) |
| ES (1) | ES535916A0 (es) |
| FI (1) | FI82838C (es) |
| GR (1) | GR80366B (es) |
| HU (1) | HU194282B (es) |
| IL (1) | IL72966A (es) |
| NO (1) | NO843664L (es) |
| NZ (1) | NZ209545A (es) |
| PH (1) | PH22422A (es) |
| PT (1) | PT79201B (es) |
| ZA (1) | ZA847258B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| DE3327928A1 (de) * | 1983-08-03 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten |
| DE3334407A1 (de) * | 1983-09-23 | 1985-04-04 | Hoechst Ag, 6230 Frankfurt | In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| DK347086D0 (da) * | 1986-07-21 | 1986-07-21 | Novo Industri As | Novel peptides |
| DK113585D0 (da) * | 1985-03-12 | 1985-03-12 | Novo Industri As | Nye peptider |
| WO1988002633A1 (en) * | 1986-10-20 | 1988-04-21 | Novo Industri A/S | Protamine zinc insulin preparations |
| DE3717370A1 (de) * | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
| DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
| DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| EP0622376B1 (de) * | 1993-04-27 | 2001-08-08 | Hoechst Aktiengesellschaft | Amorphe monosphärische Formen von Insulinderivaten |
| US6444641B1 (en) | 1997-10-24 | 2002-09-03 | Eli Lilly Company | Fatty acid-acylated insulin analogs |
| US6323311B1 (en) | 1999-09-22 | 2001-11-27 | University Of Utah Research Foundation | Synthesis of insulin derivatives |
| HUP0700126A2 (en) * | 2001-12-20 | 2007-06-28 | Lilly Co Eli | Insulin molecule having protracted time action |
| WO2004096854A2 (en) * | 2003-04-29 | 2004-11-11 | Eli Lilly And Company | Insulin analogs having protracted time action |
| DE102006031962A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
| DE102006031955A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| DK2349324T3 (en) | 2008-10-17 | 2017-12-11 | Sanofi Aventis Deutschland | COMBINATION OF AN INSULIN AND A GLP-1 AGONIST |
| ES2965209T3 (es) | 2009-11-13 | 2024-04-11 | Sanofi Aventis Deutschland | Composición farmacéutica que comprende desPro36exendina-4(1-39)-Lys6-NH2 y metionina |
| KR101836070B1 (ko) | 2009-11-13 | 2018-03-09 | 사노피-아벤티스 도이칠란트 게엠베하 | Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물 |
| CN103179978A (zh) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Ave0010用于制造供治疗2型糖尿病用的药物的用途 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| ES2550357T3 (es) | 2011-08-29 | 2015-11-06 | Sanofi-Aventis Deutschland Gmbh | Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| HRP20230470T1 (hr) | 2014-12-12 | 2023-07-21 | Sanofi-Aventis Deutschland Gmbh | Formulacija fiksnog omjera inzulin glargin/liksisenatid |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG10440A (en) * | 1970-02-07 | 1977-09-30 | Hoechst Ag | Process for the preparation of des-phenylalamin b1-insuli |
| DE2460753A1 (de) * | 1974-12-21 | 1976-06-24 | Hoechst Ag | Verfahren zur herstellung von humaninsulin |
| JPS55138393A (en) * | 1979-04-13 | 1980-10-29 | Shionogi & Co Ltd | Semisynthesis of insulin |
| EP0017938B1 (en) * | 1979-04-13 | 1983-08-03 | Shionogi & Co., Ltd. | Process for preparing a b30-threonine insulin |
| JPS55138391A (en) * | 1979-04-13 | 1980-10-29 | Shionogi & Co Ltd | New synthetic method of peptide derivative |
| DK319780A (da) * | 1980-07-24 | 1982-01-25 | Forenede Bryggerier As | Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner |
| DE3033127A1 (de) * | 1980-09-03 | 1982-04-08 | Hoechst Ag, 6000 Frankfurt | Neue analoga des insulins |
| DE3101382A1 (de) * | 1981-01-17 | 1982-09-02 | Hoechst Ag, 6000 Frankfurt | "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten" |
| DK149824C (da) * | 1982-01-22 | 1987-03-16 | Carlsberg Biotechnology Ltd | Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner |
| DE3209184A1 (de) * | 1982-03-13 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen |
| NL8201650A (nl) * | 1982-04-21 | 1983-11-16 | Akzo Nv | Semisynthetische bereiding van humane insuline. |
| DE3326472A1 (de) * | 1983-07-22 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| DE3327928A1 (de) * | 1983-08-03 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten |
| DE3334407A1 (de) * | 1983-09-23 | 1985-04-04 | Hoechst Ag, 6230 Frankfurt | In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
-
1983
- 1983-09-17 DE DE19833333640 patent/DE3333640A1/de not_active Withdrawn
-
1984
- 1984-03-17 PH PH31214A patent/PH22422A/en unknown
- 1984-09-10 HU HU843416A patent/HU194282B/hu not_active IP Right Cessation
- 1984-09-11 EP EP84110813A patent/EP0140084B1/de not_active Expired - Lifetime
- 1984-09-11 DE DE8484110813T patent/DE3482470D1/de not_active Expired - Fee Related
- 1984-09-11 AT AT84110813T patent/ATE53590T1/de not_active IP Right Cessation
- 1984-09-13 JP JP59190727A patent/JPH0691834B2/ja not_active Expired - Fee Related
- 1984-09-13 FI FI843593A patent/FI82838C/fi not_active IP Right Cessation
- 1984-09-13 CA CA000463076A patent/CA1246478A/en not_active Expired
- 1984-09-14 ZA ZA847258A patent/ZA847258B/xx unknown
- 1984-09-14 DK DK198404398A patent/DK172462B1/da not_active IP Right Cessation
- 1984-09-14 NZ NZ209545A patent/NZ209545A/xx unknown
- 1984-09-14 PT PT79201A patent/PT79201B/pt not_active IP Right Cessation
- 1984-09-14 AU AU33072/84A patent/AU577801B2/en not_active Ceased
- 1984-09-14 NO NO843664A patent/NO843664L/no unknown
- 1984-09-14 GR GR80366A patent/GR80366B/el unknown
- 1984-09-14 ES ES535916A patent/ES535916A0/es active Granted
- 1984-09-15 KR KR1019840005641A patent/KR850002282A/ko not_active Withdrawn
- 1984-09-17 IL IL72966A patent/IL72966A/xx not_active IP Right Cessation
-
1988
- 1988-03-23 US US07/172,236 patent/US5015728A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI82838B (fi) | 1991-01-15 |
| GR80366B (en) | 1985-01-11 |
| DE3482470D1 (de) | 1990-07-19 |
| HU194282B (en) | 1988-01-28 |
| AU577801B2 (en) | 1988-10-06 |
| DE3333640A1 (de) | 1985-04-25 |
| IL72966A0 (en) | 1984-12-31 |
| ATE53590T1 (de) | 1990-06-15 |
| FI843593L (fi) | 1985-03-18 |
| FI843593A0 (fi) | 1984-09-13 |
| JPS6094998A (ja) | 1985-05-28 |
| PH22422A (en) | 1988-09-12 |
| EP0140084B1 (de) | 1990-06-13 |
| AU3307284A (en) | 1985-03-21 |
| DK439884A (da) | 1985-03-18 |
| KR850002282A (ko) | 1985-05-10 |
| PT79201B (de) | 1986-09-10 |
| ES535916A0 (es) | 1985-10-01 |
| IL72966A (en) | 1989-08-15 |
| EP0140084A1 (de) | 1985-05-08 |
| JPH0691834B2 (ja) | 1994-11-16 |
| NO843664L (no) | 1985-03-18 |
| DK439884D0 (da) | 1984-09-14 |
| FI82838C (fi) | 1991-04-25 |
| US5015728A (en) | 1991-05-14 |
| HUT36144A (en) | 1985-08-28 |
| PT79201A (de) | 1984-10-01 |
| DK172462B1 (da) | 1998-08-31 |
| NZ209545A (en) | 1989-02-24 |
| ZA847258B (en) | 1985-05-29 |
| CA1246478A (en) | 1988-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8600218A1 (es) | Procedimiento para preparar un derivado de insulina | |
| ES8505646A1 (es) | Procedimiento para la preparacion de un derivado de insulina | |
| JPS55135595A (en) | Preparation of dipeptide | |
| AU530380B2 (en) | Amino acid derivatives as antihypertensives | |
| PT82173A (en) | Process for preparing novel peptides | |
| IE821911L (en) | Preparing insulin derivatives | |
| ES8504679A1 (es) | Procedimiento para la preparacion de derivados de insulina | |
| GB1464774A (en) | 13-l-norleucine-14-desamido-motilin a method for preparing it and a therapeutic containing it | |
| ES8401448A1 (es) | Procedimiento para la preparacion de insulinas a partir de compuestos analogos a preproinsulina. | |
| DE3061077D1 (en) | Solubilized thymidine composition and method of producing same | |
| IL80804A0 (en) | Process for the preparation of peptides by use of perchlorates | |
| JPS5464692A (en) | Novel synthesis of peptide derivatives | |
| JPS52106857A (en) | Preparation of 1,3-disubstituted-2-azetidinones | |
| JPS57146745A (en) | Peptide amidosulfate ester derivative and its preparation | |
| JPS57118546A (en) | Insulin derivative | |
| JPS5758694A (en) | Monobenzylphosphorylalanylproline and hypotensive comprising it | |
| JPS56104860A (en) | Preparation of beta-trihaloacetoxysulfide | |
| JPS5780399A (en) | 22-carboxylcholest-5-ene and its preparation |